The novel diagnostic method of colorectal cancer by methyl mercaptan

The novel diagnostic method of colorectal cancer by methyl mercaptan - The novel diagnostic method of colorectal cancer by methyl mercaptan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028256

Enrollment

Registered

2017-07-16

Start date

2014-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The novel diagnostic method for colorectal cancer: Detection of methyl-mercaptan from flatus.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Colorectal cancer 2)Written informed consent.

Exclusion criteria

Exclusion criteria: 1)Infectious enteritis 2)Inframmatory bowel disease 3)Bowel obstruction

Design outcomes

Primary

Measure	Time frame
the amount of methylmercaptan from flatus	—

Secondary

Measure	Time frame
the amount of CO2, H2, H2S, CH4 from flatus Correlation between colon cancer and each gas	—

Countries

Japan

Contacts

Public ContactAtsushi Ishibe

Yokohama City University Department of Gastroenterological surgery

aishibe@yokohama-cu.ac.jp0457872650

Outcome results